These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

698 related articles for article (PubMed ID: 25462194)

  • 41. Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system.
    Nishino S; Kanbayashi T
    Sleep Med Rev; 2005 Aug; 9(4):269-310. PubMed ID: 16006155
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Developmental and aging change of orexin-A and -B immunoreactive neurons in the male rat hypothalamus.
    Sawai N; Ueta Y; Nakazato M; Ozawa H
    Neurosci Lett; 2010 Jan; 468(1):51-5. PubMed ID: 19857552
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The orexin/hypocretin system in neuropsychiatric disorders: Relation to signs and symptoms.
    Fronczek R; Schinkelshoek M; Shan L; Lammers GJ
    Handb Clin Neurol; 2021; 180():343-358. PubMed ID: 34225940
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Potential role of orexin and sleep modulation in the pathogenesis of Alzheimer's disease.
    Roh JH; Jiang H; Finn MB; Stewart FR; Mahan TE; Cirrito JR; Heda A; Snider BJ; Li M; Yanagisawa M; de Lecea L; Holtzman DM
    J Exp Med; 2014 Dec; 211(13):2487-96. PubMed ID: 25422493
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The orexin system: roles in sleep/wake regulation.
    Sakurai T; Mieda M; Tsujino N
    Ann N Y Acad Sci; 2010 Jul; 1200():149-61. PubMed ID: 20633143
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Orexin/hypocretin plays a role in the response to physiological disequilibrium.
    Sinton CM
    Sleep Med Rev; 2011 Jun; 15(3):197-207. PubMed ID: 21269851
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hypothalamic prepro-orexin mRNA level is inversely correlated to the non-rapid eye movement sleep level in high-fat diet-induced obese mice.
    Tanno S; Terao A; Okamatsu-Ogura Y; Kimura K
    Obes Res Clin Pract; 2013; 7(4):e251-7. PubMed ID: 24306152
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Orexins (hypocretins) actions on the GHRH/somatostatin-GH axis.
    López M; Nogueiras R; Tena-Sempere M; Diéguez C
    Acta Physiol (Oxf); 2010 Mar; 198(3):325-34. PubMed ID: 19769635
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Involvement of hypocretins/orexins in sleep disorders and narcolepsy.
    Brown RE
    Drug News Perspect; 2003 Mar; 16(2):75-9. PubMed ID: 12792667
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hypocretin/orexin and energy expenditure.
    Teske JA; Billington CJ; Kotz CM
    Acta Physiol (Oxf); 2010 Mar; 198(3):303-12. PubMed ID: 20070282
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Orexin: a link between energy homeostasis and adaptive behaviour.
    Sakurai T
    Curr Opin Clin Nutr Metab Care; 2003 Jul; 6(4):353-60. PubMed ID: 12806206
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Increased orexin expression promotes sleep/wake disturbances in the SOD1-G93A mouse model of amyotrophic lateral sclerosis.
    Liu R; Sheng ZF; Cai B; Zhang YH; Fan DS
    Chin Med J (Engl); 2015 Jan; 128(2):239-44. PubMed ID: 25591569
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of orexin receptors in obesity: from cellular to behavioral evidence.
    Perez-Leighton CE; Butterick-Peterson TA; Billington CJ; Kotz CM
    Int J Obes (Lond); 2013 Feb; 37(2):167-74. PubMed ID: 22391883
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hypocretins (orexins): clinical impact of the discovery of a neurotransmitter.
    Baumann CR; Bassetti CL
    Sleep Med Rev; 2005 Aug; 9(4):253-68. PubMed ID: 15979356
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Difference in obesity phenotype between orexin-knockout mice and orexin neuron-deficient mice with same genetic background and environmental conditions.
    Hara J; Yanagisawa M; Sakurai T
    Neurosci Lett; 2005 Jun; 380(3):239-42. PubMed ID: 15862893
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Increase of histaminergic tuberomammillary neurons in narcolepsy.
    Valko PO; Gavrilov YV; Yamamoto M; Reddy H; Haybaeck J; Mignot E; Baumann CR; Scammell TE
    Ann Neurol; 2013 Dec; 74(6):794-804. PubMed ID: 24006291
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hypothalamic orexin system: from orphan GPCR to therapeutic target.
    Yanagisawa M
    Exp Anim; 2011; 60(3):199. PubMed ID: 21613746
    [No Abstract]   [Full Text] [Related]  

  • 58. Orexin: a potential role in the process of obstructive sleep apnea.
    Wang W; Pan Y; Li Q; Wang L
    Peptides; 2013 Apr; 42():48-54. PubMed ID: 23313149
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Orexin receptors: multi-functional therapeutic targets for sleeping disorders, eating disorders, drug addiction, cancers and other physiological disorders.
    Xu TR; Yang Y; Ward R; Gao L; Liu Y
    Cell Signal; 2013 Dec; 25(12):2413-23. PubMed ID: 23917208
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Plasticity in neurons synthesizing wake/arousal promoting hormone hypocretin/orexin.
    Gao XB
    Vitam Horm; 2012; 89():35-59. PubMed ID: 22640607
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.